Posts Tagged ‘Medtech’
Building the NHS Business Case: Creating the Case for Change Before Adoption
Most pharma, medtech and device companies accept that, sooner or later, a business case will be required to unlock meaningful NHS adoption. Teams expect to be asked for clinical evidence, cost-effectiveness data, outcomes modelling and impact projections. Many are well rehearsed in responding to those requests and invest heavily in data generation and slide decks designed to support them. And yet, despite strong…
Read MoreAdvice and Guidance: The Next Phase Of NHS Elective Transformation, From Initiative To Expectation
When I first wrote about Advice and Guidance (A&G) earlier this year, it was clear something significant was happening beneath the surface of NHS elective recovery. The idea that a GP could get specialist advice digitally before referring a patient was quietly reshaping care. It promised quicker decisions, reduced waiting lists and fewer unnecessary outpatient…
Read More